Quick Answer
Royal Jelly Skin Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: A diminished ovarian reserve (DOR) refers to a reduction in the number of recruitable follicles in the ovaries or a decline in oocyte quality, leading to decreased gamete production and reduced fertility.
Key Takeaways
- 01A diminished ovarian reserve (DOR) refers to a reduction in the number of recruitable follicles in the ovaries or a decline in oocyte quality, leading to decreased gamete production and reduced fertility. [Pi Xiangyou (2026)]
- 02In China, due to delayed childbearing, the 2-child policy, and social environmental factors, the proportion of patients with DOR is increasing, accounting for 10% of infertile women.In recent years, the prevalence of infertility has continually increased from 12% in 2007 to 18% in 2020 in China. [Pi Xiangyou (2026)]
- 03However, with advances in assisted reproductive technology, the success rate of infertility treatment has increased from 26% in 1990 to 40% to 60% in 2020. [Pi Xiangyou (2026)]
- 04Additionally, MRJPs elevate the uterine and ovarian indices and promote follicular development. [Pi Xiangyou (2026)]
The current Migaku evidence database contains 1 reusable source document for Royal Jelly Skin Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- A diminished ovarian reserve (DOR) refers to a reduction in the number of recruitable follicles in the ovaries or a decline in oocyte quality, leading to decreased gamete production and reduced fertility. [Pi Xiangyou (2026); evidence level 4]
- In China, due to delayed childbearing, the 2-child policy, and social environmental factors, the proportion of patients with DOR is increasing, accounting for 10% of infertile women.In recent years, the prevalence of infertility has continually increased from 12% in 2007 to 18% in 2020 in China. [Pi Xiangyou (2026); evidence level 4]
- However, with advances in assisted reproductive technology, the success rate of infertility treatment has increased from 26% in 1990 to 40% to 60% in 2020. [Pi Xiangyou (2026); evidence level 4]
- Additionally, MRJPs elevate the uterine and ovarian indices and promote follicular development. [Pi Xiangyou (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources